War in Ukraine could lead to ‘devastating’ tuberculosis problem, warns Anthony Fauci
Ukraine reports tens of thousands of new TB cases annually and has one of the highest rates of multi-drug-resistant TB in the world. Read more from The Telegraph.
New data shows COVID-19 combined with funding shortfalls are devastating efforts to end TB by 2030
Less than half of the required funding has been provided globally with dramatic consequences as hundreds of thousands more die from TB. Find the press release from the Stop TB Partnership here.
Historic 5‐Year Investment for Disease Intervention Specialists Workforce - $200 Million Distributed for Year 1
The Division of STD Prevention of the CDC has distributed funds for the first year of the CDC Disease Intervention Specialists (DIS) Workforce Development Supplement. See jurisdiction amount awards here.
Landmark study finds a way to reduce TB treatment regimen down to 4 months
Four months of rifapentine, moxifloxacin, isoniazid, and pyrazinamide for drug-susceptible tuberculosis was shown to be non-inferior to six months of the standard RIPE (rifampin, isoniazid, pyrazinamide, and ethambutol) regimen. Read the NEJM article here for more details, which includes a 3-minute "quick take" video summarizing the randomized trial. Shorter treatment courses help us improve quality of life for patients and get another step closer to TB elimination!
New report on governance of TB in 22 countries
The Stop TB Partnership and the United States Agency for International Development (USAID) released a new report assessing the governance of National TB Programs in 22 countries which together account for over 70% of the global TB burden. The report is envisioned to support and strengthen the performance of national-level action against TB, a preventable and curable disease, which needlessly kills 4,000 people every day.
Sign up to receive the TB Wire!
The TB Wire is an electronic newsletter, published monthly to update subscribers on the latest TB news, funding and leadership issues, calls to action, partner issues and activities, new educational products, and information about TB-related meetings. Find the sign up link here.